-+ 0.00%
-+ 0.00%
-+ 0.00%

Baixinan announced on the Hong Kong Stock Exchange that the company recently signed a strategic cooperation agreement with Shenqi Medical to jointly promote the commercialization and clinical application of the Bioheart® bioabsorbable rapamycin-eluting coronary stent system.

智通财经·09/14/2026 23:25:02
语音播报
Baixinan announced on the Hong Kong Stock Exchange that the company recently signed a strategic cooperation agreement with Shenqi Medical to jointly promote the commercialization and clinical application of the Bioheart® bioabsorbable rapamycin-eluting coronary stent system.